Abstract
Guidelines on prevention of coronary heart disease (CHD) in clinical practice have been issued by Joint Task Forces of European and other Societies1-3 and the latest update was released in 2003 by the Third Joint Task Force.3
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pyörälä K, De Backer G, Graham I, Poole-Wilson P Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994;110(2):121–161.
Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998;19(10):1434–1503.
Third Joint Task Force of European and other Societies. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003;10(Suppl 1):S1–S78.
Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83(1):356–362.
Conroy R, Pyörälä K, fitzgerald A, et al. Prediction of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.
US Preventive Services Task Force. Guide to clinical services. Baltimore: Williams & Wilkins; 1996.
EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997;18(10):1569–1582.
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22(7):554–572.
Long-term comprehensive care of cardiac patients. Recommendations by the Working Group on Rehabilitation of the European Society of Cardiology. Eur Heart J 1992;13(Suppl C):1–45.
American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for cardiac rehabilitation and secondary prevention programs. Champaign, IL: Human Kinetics; 1995.
A desktop guide to Type 1 (insulin-dependent) diabetes mellitus. European Diabetes Policy Group 1998. Diabet Med 1999;16(3):253–266.
A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med 1999;16(9):716–730.
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71–86.
Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990;323(3):147–152.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
de Backer, G. (2007). Prevention Guidelines: Management of the Coronary Patient. In: Perk, J., et al. Cardiovascular Prevention and Rehabilitation. Springer, London. https://doi.org/10.1007/978-1-84628-502-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-84628-502-8_4
Publisher Name: Springer, London
Print ISBN: 978-1-84628-462-5
Online ISBN: 978-1-84628-502-8
eBook Packages: MedicineMedicine (R0)